Background -Pleural biopsy is usually considered important for the diagnosis of pleural effusions, especially for distinguishing between tuberculosis and neoplasia, even though tuberculous pleural fluid contains sensitive biochemical markers. In regions with a high prevalence of tuberculosis, and in patient groups with a low risk of other causes of pleurisy, the positive predictive value of these markers is increased. The criteria for performing a pleural biopsy under these circumstances have been investigated, using adenosine deaminase (ADA) as a pleural fluid marker for tuberculosis. Methods -One hundred and twenty nine patients with a pleural effusion aged .35 years (mean (SD) 25 2 (4.9) years) were studied. Seventy three were men. Eighty one effusions (62.8%) were tuberculous, 12 (9.3%) parapneumonic, and 10 (7.7%) neoplastic, five were caused by pulmonary thromboembolism, four by systemic lupus erythematosus, seven by empyema, three following surgery, one was the result of asbestosis, and one ofnephrotic syndrome. In five cases no definitive diagnosis was reached. ADA levels were determined by the method of Galanti and Giusti.
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In our region, however, the incidence of tuberculosis is high (95 cases per 100 000 inhabitants) with a mean (SD) patient age of 38 (20) years at presentation.4 The prevalence of tuberculosis among all patients with a pleural effusion is likewise high at 22-4%,' and the pleura is affected in 23 3% of all tuberculous patients. These figures contrast with statistics from elsewhere such as the USA where the overall incidence of tuberculosis is only 9 3 cases per 100 000 inhabitants, the mean age at presentation is higher, and pleural effusions occur in less than 5% 67 The high prevalence of tuberculous pleurisy among cases of pleural effusion in our region means that pleural fluid levels of ADA have a higher positive predictive value.8 This prompted us to investigate whether the concomitant increase in the diagnostic efficacy ofnon-biopsy based procedures would allow pleural biopsy to be used more selectively than hitherto among patients aged < 35 years, for whom the positive predictive value of ADA levels for tuberculosis is further increased by a low incidence of neoplasia. Accordingly, in this study the cause of pleural effusions in patients in this age group was diagnosed using the usual criteria including pleural biopsy, but the diagnostic outcome was also evaluated if a more conservative approach had been used -namely, that pleural biopsy should be performed only if all other diagnostic tests gave negative results.
Methods
One hundred and twenty nine patients aged A35 years were studied in whom a pleural effusion was diagnosed before or after admission to our centre between January 1988 and June 1993. Their mean (SD) age was 25i2 (4 9) years (range 16-35); 73 were men (mean age 25 i5 (4-1) years) and 56 women (mean age 24-5 (4 8) years).
Samples ofpleural fluid and peripheral blood were taken from each patient and closed pleural biopsy was performed with a Cope9 or Abrams"0 needle. The pleural fluid was examined macroscopically, cytologically, biochemically, and microbiologically (by Ziehl-Neelsen staining and culture in Lowenstein medium and in aerobic and anaerobic media). Biochemical evaluation of both pleural fluid and blood included determination of total protein concentration, lactate dehydrogenase, cholesterol, glucose, ADA, pH, erythrocyte count, and leucocyte subsets. In no case was thoracoscopy performed.
ADA activity (U/1 at 37°C) was determined colorimetrically by the method of Galanti and Giusti. " The NH' released by deamination of adenosine added to the samples was quantified by incubation with phenol nitroprusside in an alkaline medium, followed by measurement of absorbance at 628 nm. The withinrun precision of this method in our hands was evaluated using 30 replicate high ADA samples and 30 replicate low ADA samples. The corresponding coefficients of variation were 2-24% for low ADA samples (mean (SD) 22-93 (05) U/1) and 2-02% for high ADA samples (mean 102-48 (2 04) U/1). Betweenrun precision was evaluated using 17 pairs of duplicates and a coefficient of variation of 2-51 % (mean 37-29 (0 94) U/1) was obtained.
The pleural effusions were classified as tuberculous if bacilli were identified in pleural fluid and/or biopsy cultures, or if the biopsy tissue exhibited caseating granulomas. Malignancy was diagnosed if neoplastic pleural tissue was identified or, in the case of AIDS patients already known to have cutaneous Kaposi's sarcoma, upon observation of serosanguineous pleural fluid.'2 Parapneumonic effusions were '17 For the evaluation of the non-biopsy based diagnosis of tuberculous pleurisy from levels of ADA in the pleural fluid we used a diagnostic threshold of 47 U/1, the lowest level in patients with tuberculous pleurisy aged < 35 years. This choice was justified by comparison with the values found in our reference group of 407 patients with non-tuberculous, non-empyema pleural effusions of all ages seen in our centres between January 1988 and June 1993 (see Results section). Patients with empyema were excluded from this reference group to avoid meaningless bias; empyema is known to cause high levels of ADA in the pleural fluid'8 but is easily distinguished from tuberculous pleurisy by means of other thoracocentesis based tests.
STATISTICAL ANALYSIS
For the purposes of this study "prevalence" refers to the number of cases of a given kind of pleural effusion divided by the total number of pleural effusions studied. Non-normal (nonGaussian) distributions were identified from their skew and kurtosis. The statistical significance of differences between means was estimated by the Student's t test if the variables were normally distributed, and by Wilcoxon's T test otherwise.
The values of ADA levels for the diagnosis of tuberculous pleurisy were evaluated in terms of its sensitivity, specificity, and positive predictive value (PPV); (PPV = (prevalence x sensitivity)/[(prevalence x sensitivity) + (1 -prevalence) (1 -specificity)]), and negative predictive value (NPV) =[(1 -prevalence) x specificity]/[(l -prevalence) x specificity + prevalence x (1 -sensitivity)]).
Results
The diagnoses of the 129 patients are listed in table 1. As expected, among our patients with pleural effusions aged < 35 years the prevalence of tuberculous effusions was very high (63% (81/129) compared with 22-4% for patients of all ages with effusions in this region).' The prevalence of neoplastic effusions was low at 7-7% (10/129) compared with 27-1% for patients of all ages with effusions.' Table 2 summarises the microbiological and histological results among the patients for 20 U/i). Thus, all the patients aged . 35 years (and 96-7% of the whole reference group) had pleural ADA concentrations below 47 U/l, the lowest level seen in the patients with tuberculous pleurisy aged below 35 years. Since in this context false negatives are preferable to false positives (because patients for whom all non-biopsy based analyses are negative will be subjected to biopsy), the diagnostic threshold chosen was 47 U/l. With this threshold the sensitivity of pleural ADA concentrations for tuberculosis among patients aged .35 years with an effusion was 100% and its specificity 87-5%. All the false positives were empyemas. The positive predictive value was 93 1% and the negative predictive value 100% (figure). For eight of the 10 patients with neoplastic effusions diagnosis was reached by pleural fluid analysis, and included two with Kaposi's sarcoma, two with non-Hodgkin's lymphoma, and four with metastatic adenocarcinomas. Analysis of biopsy tissue diagnosed six metastatic effusions (the above four plus one metastatic seminoma and one metastatic bronchogenic epidermoid), but not the other neoplastic cases.
Discussion
Thoracocentesis and pleural biopsy are both performed routinely for the diagnosis of pleural effusions. Although the determination of pleural fluid levels of ADA and interferon y for the diagnosis of tuberculous pleurisy is increasing, analysis of biopsy tissue is often considered obligatory for definitive diagnosis oftuberculous and neoplastic effusions,'920 despite the diagnostic sensitivity ofbiopsy for these two conditions being only 75% and 57% respectively.2'
As a result of the epidemiological characteristics of tuberculosis in our region, its prevalence among cases of pleural effusion is high at 22A4%.3 We therefore reasoned that the positive predictive value of pleural fluid levels of ADA for tuberculous pleurisy should be better than in regions of lower prevalence, especially among patients with a low probability of neoplasia (who may also have high ADA levels3).
With a concentration of ADA in pleural fluid of >47 U/I as a diagnostic criterion, the sensitivity and negative predictive value of ADA levels for the diagnosis of tuberculous pleurisy were both 100%. The only other effusions with pleural fluid concentrations of ADA above this level occurred with empyemas, making the specificity of pleural ADA concentrations for tuberculous pleurisy in this age group 87-5%. The only effusions that were diagnosed at biopsy but not by other procedures were two of the six patients with metastatic disease. Both these cases fulfilled the conservative criteria for biopsy that we wished to test (ADA concentration below 47 U/1, negative cytology, and the absence of other positive indications for the cause of the effusion). In this sample ofpatients the conservative criteria would therefore have left no cases undiagnosed that were not also left undiagnosed by immediate biopsy.
In general, the only cases in which our conservative criteria would have led to misdiagnosis, but which might conceivably be diagnosed correctly using immediate biopsy, are cases of neoplastic effusion with negative cytological results and high pleural concentrations of ADA. It is necessary to stress "might" because it is estimated that the 66% sensitivity of cytology for neoplastic effusions is only increased to 73% if both biopsy and cytology are used,23 and it is questionable whether any of the patients making up the 7% difference will have high pleural concentrations of ADA. Since this is an important issue we feel that more data from other areas with high rates of tuberculosis are needed to establish an accurate estimate of the probability that a patient with a pleural effusion aged < 35 years with negative cytological results, a high concentration of ADA in the pleural fluid, and no other diagnosis has a malignancy rather than tuberculosis.
Nevertheless, our results show that, in a region of high tuberculosis prevalence, routine determination of pleural fluid concentrations ofADA in young patients with pleural effusions can provide a very reliable basis for deciding whether to start antituberculous therapy before the results of biopsy or culture become available. 
